164 related articles for article (PubMed ID: 36367353)
21. The Clinical Significance of Procalcitonin Elevation in Patients over 75 Years Old Admitted for COVID-19 Pneumonia.
Ticinesi A; Nouvenne A; Prati B; Guida L; Parise A; Cerundolo N; Bonaguri C; Aloe R; Guerra A; Meschi T
Mediators Inflamm; 2021; 2021():5593806. PubMed ID: 34326704
[TBL] [Abstract][Full Text] [Related]
22. Serum procalcitonin levels predict acute kidney injury in critically ill patients.
Jeeha R; Skinner DL; De Vasconcellos K; Magula NP
Nephrology (Carlton); 2018 Dec; 23(12):1090-1095. PubMed ID: 28967168
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic value of Charlson weighted index of comorbidities combined with sequential organ failure assessment score and procalcitonin in patients with sepsis].
Zhang X; Wang Q; Luo X; Lei Y; Huang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1335-1339. PubMed ID: 31898562
[TBL] [Abstract][Full Text] [Related]
25. The Association between Admission Procalcitonin Level and The Severity of COVID-19 Pneumonia: A Retrospective Cohort Study.
Aon M; Alsaeedi A; Alzafiri A; Ibrahim MM; Al-Shammari A; Al-Shammari O; Tawakul M; Taha S; Alherz N; Alshammari J; Albazee E; Alharbi T; Alshammari D; Alenezi Z; Alenezi M; Aldouseri S; Eyadah M; Aldhafeeri M; Aoun AH
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295550
[TBL] [Abstract][Full Text] [Related]
26. Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
López-Ayala P; Alcaraz-Serna A; Valls Carbó A; Cuadrado Cenzual MÁ; Torrejón Martínez MJ; López Picado A; Martínez Valero C; Miranda JD; Díaz Del Arco C; Cozar López G; Suárez-Cadenas MDM; Jerez Fernández P; Angós B; Rodríguez Adrada E; Cardassay E; Del Toro E; Chaparro D; Montalvo Moraleda MT; Espejo Paeres C; García Briñón MÁ; Hernández Martín-Romo V; Ortega L; Fernández Pérez C; Martínez-Novillo M; González Armengol JJ; González Del Castillo J; Mueller CE; Martín-Sánchez FJ;
Emergencias; 2022 Apr; 34(2):119-127. PubMed ID: 35275462
[TBL] [Abstract][Full Text] [Related]
27. Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana.
Lunski MJ; Burton J; Tawagi K; Maslov D; Simenson V; Barr D; Yuan H; Johnson D; Matrana M; Cole J; Larned Z; Moore B
Cancer; 2021 Jan; 127(2):266-274. PubMed ID: 33112411
[TBL] [Abstract][Full Text] [Related]
28. [Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].
Hao C; Hu Q; Zhu L; Xu H; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):281-285. PubMed ID: 33834968
[TBL] [Abstract][Full Text] [Related]
29. Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies.
Shen Y; Cheng C; Zheng X; Jin Y; Duan G; Chen M; Chen S
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34207689
[No Abstract] [Full Text] [Related]
30. Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19.
Wongvibulsin S; Garibaldi BT; Antar AAR; Wen J; Wang MC; Gupta A; Bollinger R; Xu Y; Wang K; Betz JF; Muschelli J; Bandeen-Roche K; Zeger SL; Robinson ML
Ann Intern Med; 2021 Jun; 174(6):777-785. PubMed ID: 33646849
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
32. Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19.
Jackson I; Jaradeh H; Aurit S; Aldamen A; Narechania S; Destache C; Velagapudi M
Int J Infect Dis; 2022 Jun; 119():47-52. PubMed ID: 35358722
[TBL] [Abstract][Full Text] [Related]
33. Association between platelet indices and the severity of the disease and mortality in patients with COVID-19.
Yardımcı AC; Yıldız S; Ergen E; Ballı H; Ergene E; Guner YS; Karnap M; Demırbas Keskın D; Yuksel H; Bocutoglu F; Akbel VC; Kalyoncu D
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6731-6740. PubMed ID: 34787878
[TBL] [Abstract][Full Text] [Related]
34. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
Zare ME; Wang Y; Nasir Kansestani A; Almasi A; Zhang J
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):557-569. PubMed ID: 33463126
[TBL] [Abstract][Full Text] [Related]
35. Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans.
Ashktorab H; Pizuorno A; Adeleye F; Laiyemo A; Dalivand MM; Aduli F; Sherif ZA; Oskrochi G; Angesom K; Oppong-Twene P; Challa SR; Okorie N; Moon ES; Romos E; Jones-Wonni B; Kone AM; Rankine S; Thrift C; Scholes D; Ekwunazu C; Banson A; Mitchell B; Maskalo G; Ross J; Curtis J; Kim R; Gilliard C; Ahuja G; Mathew J; Gavin W; Kara A; Hache-Marliere M; Palaiodimos L; Mani VR; Kalabin A; Gayam VR; Garlapati PR; Miller J; Chirumamilla LG; Jackson F; Carethers JM; Kamangar F; Brim H
BMC Infect Dis; 2022 Jun; 22(1):552. PubMed ID: 35715729
[TBL] [Abstract][Full Text] [Related]
36. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China.
Xu JB; Xu C; Zhang RB; Wu M; Pan CK; Li XJ; Wang Q; Zeng FF; Zhu S
Sci Rep; 2020 Sep; 10(1):15058. PubMed ID: 32929124
[TBL] [Abstract][Full Text] [Related]
37. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
[TBL] [Abstract][Full Text] [Related]
38. Serial cardiac biomarkers for risk stratification of patients with COVID-19.
Tawiah K; Jackson L; Omosule C; Ballman C; Shahideh B; Scott MG; Murtagh G; Farnsworth CW
Clin Biochem; 2022 Sep; 107():24-32. PubMed ID: 35691587
[TBL] [Abstract][Full Text] [Related]
39. Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study.
Zattera L; Veliziotis I; Benitez-Cano A; Ramos I; Larrañaga L; Nuñez M; Román L; Adalid I; Ferrando C; Muñoz G; Arruti E; Minini A; Bassas E; Hernández M; Taccone FS; Peluso L; Adalia R;
Minerva Anestesiol; 2022 Apr; 88(4):259-271. PubMed ID: 35072432
[TBL] [Abstract][Full Text] [Related]
40. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
